Country selection
To offer the best possible experience tailored to your national regulatory requirements and the available product portfolio, please choose your country from the following list. This option will be saved throughout the browser session. Thank you!
User experience & privacy
We use cookies to offer you an optimal website experience. This includes cookies necessary for the operation of the website and for the control of our commercial corporate goals, as well as those only used for anonymous statistical purposes, comfort settings or to display personalized content. Please note that based on your settings, not all functions of the website may be available. To find out more, please refer to our Data Privacy Statement.

Eckert & Ziegler Receives Approval for Gallium-68 Generator for Brazil


Eckert & Ziegler Radiopharma GmbH has received approval for its pharmaceutical 68Ge/68Ga generator GalliaPharm(R) from the Brazilian health authority ANVISA. GalliaPharm(R) is thus the first and currently the only pharmaceutical gallium generator approved in Brazil.

“The approval strengthens our market position in Brazil and marks another milestone in our expansion strategy”, explains Dr. Lutz Helmke, Executive Director of Eckert & Ziegler AG and responsible for the Medical segment. “Since there are currently many clinical studies with so-called theranostics worldwide, we expect an increasing demand for both the diagnostic radioisotope gallium-68 and the therapeutic radioisotope lutetium-177 in the next few years”.

GalliaPharm(R) is already successfully used in combination with approved kits, for the diagnosis of neuroendocrine tumors and in clinical trials also for prostate cancer (Ga-68-PSMA kit).

In Brazil, more than 590.000 new cases of cancer have been reported in 2020, with 97.278 in prostate, followed by breast (88.492) and colorectum cancer (55.102). (Source: IARC Global Cancer Observatory, 2020).

Gallium generators offer a low-cost alternative to radioactive labeling of biomolecules with gallium-68 in PET, an imaging examination method used to detect the presence or absence of diseased tissue. The procedure is used primarily in the diagnosis of cancer, heart attacks or neurological diseases. Up to now, the radioisotopes fluorine-18 or carbon-11 have mostly been used to label biomolecules. This requires millions of dollars of investment in large-scale equipment (cyclotrons). The 68Ge/68Ga generator, on the other hand, is about the size of a thermos flask and can be obtained much more cheaply, which reduces costs and increases flexibility in nuclear medical clinics and practices.


Get in touch

Contact us regarding your questions and we will get back to you as soon as possible.
By clicking send, you give your consent for processing your personal data in accordance with our Data Privacy Statement.
Permission required
In order to submit your request it is required to load a 3rd-party service (Google Re-Captcha spam protection system). You current privacy settings prevent this from happening automatically. By clicking the button below you explicitly allow to temporarily (on this page) load 3rd party services.